Health Care & Hospital Law,
Civil Litigation
Aug. 3, 2022
Companies failed to warn prenatal dangers of pain medication, lawsuits say
“Scientific and epidemiological research shows that prenatal exposure to APAP alters fetal development significantly increasing the risks of neurodevelopmental disorders,” wrote Khaldoun A. Baghdadi of Walkup Melodia Kelly & Schoenberger.
Six nearly identical lawsuits were filed against Walgreens Boot Alliance, CVS Health Corp. and Walmart Inc. alleging the companies annually sold billions of units of pain relief medication while failing to warn consumers of the threat that prenatal exposure to the products significantly increases the risk of neurodevelopmental disorders in fetuses.
Plaintiffs in San Francisco, Oakland and San Jose claimed that Paracetamol, also known as A...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In